Követés
Håkon Reikvam
Håkon Reikvam
Ismeretlen szervezet
E-mail megerősítve itt: med.uib.no
Cím
Hivatkozott rá
Hivatkozott rá
Év
Thrombelastography
H Reikvam, E Steien, B Hauge, K Liseth, KG Hagen, R Størkson, T Hervig
Transfusion and Apheresis Science 40 (2), 119-123, 2009
2422009
The PI3K-Akt-mTOR signaling pathway in human acute myeloid leukemia (AML) cells
I Nepstad, KJ Hatfield, IS Grønningsæter, H Reikvam
International journal of molecular sciences 21 (8), 2907, 2020
2122020
Acute myeloid leukemia with the t (8; 21) translocation: clinical consequences and biological implications
H Reikvam, KJ Hatfield, AO Kittang, R Hovland, Ø Bruserud
BioMed Research International 2011, 2011
1562011
The crosstalk between the matrix metalloprotease system and the chemokine network in acute myeloid leukemia
K J Hatfield, H Reikvam, O Bruserud
Current medicinal chemistry 17 (36), 4448-4461, 2010
1162010
Hyperferritinemia—a clinical overview
M Sandnes, RJ Ulvik, M Vorland, H Reikvam
Journal of Clinical Medicine 10 (9), 2008, 2021
952021
Therapeutic targeting the cell division cycle 25 (CDC25) phosphatases in human acute myeloid leukemia—the possibility to target several kinases through inhibition of the …
AK Brenner, H Reikvam, A Lavecchia, Ø Bruserud
Molecules 19 (11), 18414-18447, 2014
922014
Venous thromboembolism in patients with essential thrombocythemia and polycythemia vera
H Reikvam, RV Tiu
Leukemia 26 (4), 563-571, 2012
902012
The chemokine network in acute myelogenous leukemia: molecular mechanisms involved in leukemogenesis and therapeutic implications
AO Kittang, K Hatfield, K Sand, H Reikvam, Ø Bruserud
The Chemokine System in Experimental and Clinical Hematology, 149-172, 2010
822010
Febrile neutropenia in acute leukemia. Epidemiology, etiology, pathophysiology and treatment
BA Hansen, Ø Wendelbo, Ø Bruserud, AL Hemsing, KA Mosevoll, ...
Mediterranean journal of hematology and infectious diseases 12 (1), 2020
772020
Heat shock protein 90-a potential target in the treatment of human acute myelogenous leukemia
H Reikvam, E Ersvaer, O Bruserud
Current cancer drug targets 9 (6), 761-776, 2009
742009
The cytokine-mediated crosstalk between primary human acute myeloid cells and mesenchymal stem cells alters the local cytokine network and the global gene expression profile of …
H Reikvam, AK Brenner, KM Hagen, K Liseth, S Skrede, KJ Hatfield, ...
Stem cell research 15 (3), 530-541, 2015
692015
Primary human acute myelogenous leukemia cells release matrix metalloproteases and their inhibitors: release profile and pharmacological modulation
H Reikvam, KJ Hatfield, AM Øyan, KH Kalland, AO Kittang, Ø Bruserud
European journal of haematology 84 (3), 239-251, 2010
662010
Nuclear factor-κB signaling: a contributor in leukemogenesis and a target for pharmacological intervention in human acute myelogenous leukemia
H Reikvam, AM Olsnes, BT Gjertsen, E Ersvar, O Bruserud
Critical Reviews™ in Oncogenesis 15 (1-2), 2009
662009
Cytokines, adhesion molecules, and matrix metalloproteases as predisposing, diagnostic, and prognostic factors in venous thrombosis
KA Mosevoll, S Johansen, Ø Wendelbo, I Nepstad, Ø Bruserud, ...
Frontiers in medicine 5, 147, 2018
652018
Extracorporeal photopheresis (photochemotherapy) in the treatment of acute and chronic graft versus host disease: immunological mechanisms and the results from clinical studies
Ø Bruserud, THA Tvedt, PQ Paulsen, AB Ahmed, T Gedde-Dahl, ...
Cancer Immunology, Immunotherapy 63, 757-777, 2014
612014
The Mirasol® Pathogen Reduction Technology system and quality of platelets stored in platelet additive solution
H Reikvam, S Marschner, TO Apelseth, R Goodrich, T Hervig
Blood Transfusion 8 (3), 186, 2010
582010
Inflammatory mediator profiles differ in sepsis patients with and without bacteremia
KA Mosevoll, S Skrede, DL Markussen, HR Fanebust, HK Flaatten, ...
Frontiers in Immunology 9, 691, 2018
572018
Identification of a subset of patients with acute myeloid leukemia characterized by long-term in vitro proliferation and altered cell cycle regulation of the leukemic cells
KJ Hatfield, H Reikvam, Ø Bruserud
Expert opinion on therapeutic targets 18 (11), 1237-1251, 2014
572014
Expression profile of heat shock proteins in acute myeloid leukaemia patients reveals a distinct signature strongly associated with FLT3 mutation status …
H Reikvam, KJ Hatfield, E Ersvaer, R Hovland, J Skavland, BT Gjertsen, ...
British journal of haematology 156 (4), 468-480, 2012
572012
The angioregulatory cytokine network in human acute myeloid leukemia-from leukemogenesis via remission induction to stem cell transplantation.
H Reikvam, KJ Hatfield, H Fredly, I Nepstad, KA Mosevoll, Ø Bruserud
European cytokine network 23 (4), 140-153, 2012
552012
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20